[1]
A. H. A. A. Khan, “Serum level of IL-37 as a modulator in atherosclerosis, correlating its levels with oxidative stress and disease progression”, Regul. Mech. Biosyst., vol. 16, no. 2, p. e25076, Jul. 2025.